The Discounted Cash Flow (DCF) valuation of Exagen Inc (XGN) is (18.05) USD. With the latest stock price at 4.58 USD, the upside of Exagen Inc based on DCF is -494.2%.
Based on the latest price of 4.58 USD and our DCF valuation, Exagen Inc (XGN) is a sell. selling XGN stocks now will result in a potential gain of 494.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 9.1% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (54.52) - (11.25) | (18.05) |
| Upside | -1290.4% - -345.6% | -494.2% |